CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2013
CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract]
Revenues	$ 379	$ 379	$ 679
Cost of revenues	(13)	(11)	(20)
Gross profit	366	368	659
Research and development expenses	(23,416)	(24,938)	(19,906)
Less participation by the Office of the Chief Scientist and other parties	4,243	5,396	2,673
Research and development expenses, net	(19,173)	(19,542)	(17,233)
General and administrative expenses	(6,460)	(8,676)	(5,649)
Operating loss	(25,267)	(27,850)	(22,223)
Financial income, net	590	918	1,068
Net loss	$ (24,677)	$ (26,932)	$ (21,155)
Loss per share:
Basic and diluted net loss per share	$ (0.35)	$ (0.42)	$ (0.38)
Weighted average number of shares used in computing basic and diluted net loss per share	70,284,337	63,514,405	55,481,357